Sabre Corp (SABR) concluded trading on Wednesday at a closing price of $2.98, with 9.52 million shares of worth about $28.36 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -21.58% during that period and on June 25, 2025 the price saw a gain of about 1.71%. Currently the company’s common shares owned by public are about 387.66M shares, out of which, 356.84M shares are available for trading.
Stock saw a price change of 11.61% in past 5 days and over the past one month there was a price change of 17.09%. Year-to-date (YTD), SABR shares are showing a performance of 8.36% which decreased to -18.36% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.93 but also hit the highest price of $4.63 during that period. The average intraday trading volume for Sabre Corp shares is 6.67 million. The stock is currently trading 9.14% above its 20-day simple moving average (SMA20), while that difference is up 15.73% for SMA50 and it goes to -8.53% lower than SMA200.
Sabre Corp (NASDAQ: SABR) currently have 387.66M outstanding shares and institutions hold larger chunk of about 92.80% of that.
The stock has a current market capitalization of $1.16B and its 3Y-monthly beta is at 1.40. It has posted earnings per share of -$0.46 in the same period. It has Quick Ratio of 1.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SABR, volatility over the week remained 2.85% while standing at 3.77% over the month.
Stock’s fiscal year EPS is expected to rise by 160.62% while it is estimated to increase by 244.12% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Bernstein on April 01, 2025 offering a Mkt perform rating for the stock and assigned a target price of $3.50 to it. Coverage by BofA Securities stated Sabre Corp (SABR) stock as a Buy in their note to investors on March 04, 2025, suggesting a price target of $6.10 for the stock. On January 07, 2025, Cantor Fitzgerald Downgrade their recommendations, while on November 19, 2024, Bernstein Downgrade their ratings for the stock with a price target of $3. Stock get an Overweight rating from Cantor Fitzgerald on February 21, 2024.
